HLA-E and cancer: TCRs can also recognize HLA-E–peptide complexes [10], and HLA-E-restricted CD8+ T cells have been identified in the circulation in patients with malignancies and infections, as we have shown previously in active TB (aTB) or Mtb-infected (TBI) individuals with and without HIV co-infection [11,12].